[{"address1": "11250 El Camino Real", "address2": "Suite 100", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 410 0266", "website": "https://skyebioscience.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Skye Bioscience, Inc., a biopharmaceutical company, focuses on unlocking new therapeutic pathways for metabolic health through the development of molecules that modulate G-protein coupled receptors. The company is conducting a Phase 2 clinical trial in obesity for nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1. This study is also assessing the combination of nimacimab and a GLP-1R agonist (Wegovy). The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.", "fullTimeEmployees": 11, "companyOfficers": [{"maxAge": 1, "name": "Ms. Kaitlyn Melanie Arsenault CPA", "age": 36, "title": "Chief Financial Officer", "yearBorn": 1987, "fiscalYear": 2023, "totalPay": 476000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher G. Twitty Ph.D.", "age": 50, "title": "Chief Scientific Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tu  Diep M.Sc.", "age": 42, "title": "Chief Development Officer", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Puneet S. Arora FACE, M.D., M.S.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.22, "open": 5.2, "dayLow": 4.9, "dayHigh": 5.2, "regularMarketPreviousClose": 5.22, "regularMarketOpen": 5.2, "regularMarketDayLow": 4.9, "regularMarketDayHigh": 5.2, "beta": 1.786, "forwardPE": -4.3504276, "volume": 171433, "regularMarketVolume": 171433, "averageVolume": 330953, "averageVolume10days": 230400, "averageDailyVolume10Day": 230400, "bid": 5.04, "ask": 6.28, "bidSize": 100, "askSize": 200, "marketCap": 154421952, "fiftyTwoWeekLow": 1.44, "fiftyTwoWeekHigh": 19.41, "fiftyDayAverage": 4.9476, "twoHundredDayAverage": 8.232385, "currency": "USD", "enterpriseValue": 85369640, "floatShares": 17436932, "sharesOutstanding": 30338300, "sharesShort": 1417276, "sharesShortPriorMonth": 1126682, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0467, "heldPercentInsiders": 0.01893, "heldPercentInstitutions": 0.84566003, "shortRatio": 2.43, "shortPercentOfFloat": 0.0699, "bookValue": 2.594, "priceToBook": 1.9622205, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -42288112, "trailingEps": -3.6, "forwardEps": -1.17, "enterpriseToEbitda": -3.877, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "SKYE", "underlyingSymbol": "SKYE", "shortName": "Skye Bioscience, Inc.", "longName": "Skye Bioscience, Inc.", "firstTradeDateEpochUtc": 1420554600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f0ec0a4d-b670-3424-93a4-f9095a3b0984", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.09, "targetHighPrice": 21.0, "targetLowPrice": 14.0, "targetMeanPrice": 18.0, "targetMedianPrice": 19.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 74120856, "totalCashPerShare": 2.443, "ebitda": -22021516, "totalDebt": 5068597, "quickRatio": 5.213, "currentRatio": 6.075, "debtToEquity": 6.961, "returnOnAssets": -0.30917, "returnOnEquity": -1.30078, "freeCashflow": -20986360, "operatingCashflow": -19701078, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-31"}]